First Time NDA Filed in Japan for Meningococcal Vaccine: Sanofi

March 28, 2013
Sanofi K.K. and Sanofi Pasteur K.K. announced on March 26 that Sanofi K.K. filed a new drug application (NDA) for its meningococcal vaccine (meningococcal polysaccharide diphtheria toxoid conjugate vaccine) on the same day. This is the first NDA to be...read more